Marden-Walker syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2461OMIM:248700Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Marden-Walker syndrome (MWS) is an extremely rare congenital disorder characterized by a distinctive combination of fixed facial expression (mask-like facies), blepharophimosis (narrowing of the eye openings), joint contractures, and psychomotor developmental delay. The condition is present from birth and affects multiple body systems, including the musculoskeletal, neurological, and craniofacial systems. Key clinical features include a fixed, immobile facial expression, micrognathia (small jaw), cleft or high-arched palate, low-set ears, and decreased muscle mass. Joint contractures, particularly of the limbs, are a hallmark feature and may limit mobility. Affected individuals frequently exhibit significant intellectual disability and delayed motor milestones. Additional findings may include growth retardation, arachnodactyly (long slender fingers), kyphoscoliosis, and in some cases, renal anomalies or congenital heart defects. Brain abnormalities such as Dandy-Walker malformation or agenesis of the corpus callosum have been reported in some patients. The neurological involvement in Marden-Walker syndrome can be substantial, with many affected individuals showing reduced or absent deep tendon reflexes and generalized hypotonia in infancy that may evolve into hypertonia. Some patients may experience seizures. Connective tissue abnormalities may also be present. The syndrome shares clinical overlap with Schwartz-Jampel syndrome and other conditions involving joint contractures and facial dysmorphism, making careful clinical and genetic evaluation important for accurate diagnosis. There is currently no cure or specific targeted therapy for Marden-Walker syndrome. Treatment is supportive and symptomatic, focusing on physical therapy and orthopedic interventions for joint contractures, developmental support services for intellectual disability, and management of any associated cardiac, renal, or neurological complications. A multidisciplinary approach involving geneticists, neurologists, orthopedic specialists, and developmental pediatricians is recommended. Prognosis varies, but the condition can be associated with significant morbidity, and some cases have been reported with early mortality.

Clinical phenotype terms— hover any for plain English:

Aplasia/Hypoplasia involving the skeletal musculatureHP:0001460
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Marden-Walker syndrome.

View clinical trials →

No actively recruiting trials found for Marden-Walker syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Marden-Walker syndrome community →

No specialists are currently listed for Marden-Walker syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Marden-Walker syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Marden-Walker syndromeForum →

No community posts yet. Be the first to share your experience with Marden-Walker syndrome.

Start the conversation →

Latest news about Marden-Walker syndrome

No recent news articles for Marden-Walker syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Marden-Walker syndrome

What is Marden-Walker syndrome?

Marden-Walker syndrome (MWS) is an extremely rare congenital disorder characterized by a distinctive combination of fixed facial expression (mask-like facies), blepharophimosis (narrowing of the eye openings), joint contractures, and psychomotor developmental delay. The condition is present from birth and affects multiple body systems, including the musculoskeletal, neurological, and craniofacial systems. Key clinical features include a fixed, immobile facial expression, micrognathia (small jaw), cleft or high-arched palate, low-set ears, and decreased muscle mass. Joint contractures, particul

How is Marden-Walker syndrome inherited?

Marden-Walker syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Marden-Walker syndrome typically begin?

Typical onset of Marden-Walker syndrome is neonatal. Age of onset can vary across affected individuals.